BCM
Bayesian Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,700
| Closed | -$502K | – | 602 |
|
|
2025
Q1 | $502K | Buy |
+20,700
| New | +$502K | 0.08% | 293 |
|
|
2024
Q4 | – | Sell |
-14,741
| Closed | -$293K | – | 734 |
|
|
2024
Q3 | $293K | Buy |
+14,741
| New | +$293K | 0.03% | 482 |
|
|
2024
Q2 | – | Sell |
-23,400
| Closed | -$373K | – | 806 |
|
|
2024
Q1 | $373K | Buy |
+23,400
| New | +$373K | 0.04% | 505 |
|
|
2020
Q2 | – | Sell |
-12,003
| Closed | -$46K | – | 564 |
|
|
2020
Q1 | $46K | Buy |
+12,003
| New | +$46K | 0.01% | 731 |
|
|
2019
Q3 | – | Sell |
-27,100
| Closed | -$104K | – | 542 |
|
|
2019
Q2 | $104K | Buy |
+27,100
| New | +$104K | 0.02% | 460 |
|